Skip to content
WeighLab

CoreAge Rx vs REMEVi

Compare the prices, treatment options and tradeoffs that matter before you choose a GLP-1 program.

By The WeighLab Bench. Provider verification dates appear below.

REMEVi

Provider comparison

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Semaglutide / month
$199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
$269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Index 82/100 · Grade B−Checked October 2026

We may earn a commission if you sign up through a provider link, at no extra cost to you. Compensation does not change scores. How we earn money.

The comparison in brief

CoreAge Rx has the higher Cost-Efficiency Index: 94/100 versus 82/100. That is a value comparison under our published methodology, not a measure of medical suitability or a guarantee of results.

Check the difference in state access

CoreAge Rx
All 50 states
REMEVi
49 states + DC

The better fit depends on what is included in your quote. A lower advertised price can require prepayment, apply to a starting dose or leave out a separate fee.

How the comparison is scored

Costs & coverage

Published prices with their terms intact. Annual estimates account for billing frequency and known fixed required fees; they are not a treatment quote.

CoreAge Rx

REMEVi

Semaglutide / month
CoreAge Rx: $99/mo
REMEVi: $199 per 4 weeksMonth-to-month, same at every dose; $159 per 4 weeks on a 24-week plan paid up front, compounded
Tirzepatide / month
CoreAge Rx: $149/mo
REMEVi: $269 per 4 weeksMonth-to-month, same at every dose; $225 per 4 weeks on a 24-week plan paid up front, compounded
Semaglutide / year (modeled)
CoreAge Rx: $1,188
REMEVi: $2,58713 charges
Tirzepatide / year (modeled)
CoreAge Rx: $1,788
REMEVi: $3,49713 charges
State availability
CoreAge Rx: All 50 states
REMEVi: 49 states + DC
Oral / sublingual option listed
CoreAge Rx: Not listed
REMEVi: Yes
Brand-name access listed
CoreAge Rx: Not confirmed
REMEVi: Not confirmed
Provider facts checked
CoreAge Rx: October 2026
REMEVi: October 2026

Comparing different billing plans? See what a GLP-1 monthly price can leave out, or calculate the monthly cost.

Which program fits your priorities?

The strengths and limitations behind each provider's score. Read the full review before deciding.

CoreAge Rx

Anyone who wants one flat monthly price they can plan a full year around, on either molecule, without signing a contract.

Reasons to consider it

  • One price at every dose: semaglutide is $99 from 0.25 mg up to 2.5 mg, and tirzepatide is $149 from 2.5 mg up to 15 mg
  • No membership fee, no insurance needed and no long-term contract, and the price you lock in at checkout stays put as your dose rises
  • If the doctor decides a prescription isn't right for you, CoreAge refunds the medication portion of your payment

What to weigh up

  • Some programs we track publish lower semaglutide prices. Compare billing terms, dose pricing and required fees before choosing.
  • You pay before the doctor reviews your case, and if you aren't approved the FAQ promises a 100% refund while the refund policy keeps a $50 to $100 consultation fee
  • All sales are final once medication ships, because state and federal law don't allow medication returns

REMEVi

Spanish- and English-speaking shoppers who want LegitScript-certified compounded GLP-1 care in their own language.

Reasons to consider it

  • A genuinely flat rate: 'the same price at every dose', stated as such, with no dose upcharge and no introductory rate to step off
  • Longer terms are published openly rather than used as a teaser: semaglutide falls to $169 every 4 weeks on a 12-week plan and $159 on a 24-week plan
  • A daily oral semaglutide tablet is offered alongside the injection

What to weigh up

  • Billing runs every 4 weeks, so a year of month-to-month care is 13 charges, and the lowest $159 rate needs 24 weeks paid up front
  • No FDA-approved brand-name pathway — the Wegovy and Ozempic pages are comparison content, not products
  • Compounded semaglutide and tirzepatide are not FDA-approved finished products

Explore the six scoring factors

Scores run from 0 to 100. A higher factor score reflects our published value criteria; it is not a clinical endorsement.

CoreAge RxREMEVi
Normalized Cost/Month
CoreAge Rx:
93/100
REMEVi:
74/100
Price Transparency
CoreAge Rx:
97/100
REMEVi:
94/100
Nationwide Access
CoreAge Rx:
98/100
REMEVi:
86/100
Formulation Options
CoreAge Rx:
84/100
REMEVi:
77/100
Clinical Oversight
CoreAge Rx:
90/100
REMEVi:
87/100
Contract Flexibility
CoreAge Rx:
95/100
REMEVi:
69/100

Before you sign up

  • Confirm your totalAsk about dose changes, membership, labs, shipping and cancellation terms.
  • Check treatment accessState coverage and medical eligibility can differ by medication and formulation.
  • Understand the medicationCompare compounded and brand-name options. Compounded drugs are not FDA-approved.

Keep comparing

Choose a different comparison

Provider information reflects public disclosures at the verification dates shown. Prices and availability change; confirm current terms before paying. This comparison is for information, not medical advice. A licensed clinician determines whether treatment is appropriate.